Vibalogics
Vibalogics's Overview
Vibalogics is a specialized Contract Development and Manufacturing Organization (CDMO) providing process and analytical development, GMP manufacturing, and fill-finish services for viral vectors, oncolytic viruses, and viral vaccines. With facilities in Germany and the USA, Vibalogics supports clients from preclinical stages through to commercial supply. Acquired by Recipharm in 2022, Vibalogics' capabilities are now integrated into Recipharm's broader biologics offering, enhancing its global service network for advanced therapy medicinal products (ATMPs).
Where is Vibalogics's Headquarters?
HQ Function
Serves as a major European hub for process development, GMP manufacturing of viral vectors, quality control, and project management. It supports clinical and commercial scale production.
Notable Features:
State-of-the-art BSL-2 and BSL-3 cleanroom facilities, advanced analytical laboratories, and capabilities for drug substance and drug product manufacturing.
Work Culture:
A science-driven and quality-focused environment, emphasizing innovation, collaboration, and precision in biomanufacturing. As a CDMO, the culture is client-centric and adaptable to diverse project needs.
HQ Significance:
The Cuxhaven site is significant for its specialized expertise in virotherapy and its role in the supply chain for advanced therapies in Europe and globally. It represents a key asset in Recipharm's biologics division.
Values Reflected in HQ: The facility reflects values of scientific excellence, cutting-edge technology, stringent quality standards, and reliability in delivering complex biopharmaceutical products.
Location:
Through its facilities in Germany and the USA, now part of Recipharm's global network, Vibalogics supports clients worldwide. Services include process development, GMP manufacturing, and analytical testing for viral vectors, catering to a global demand for advanced therapies and vaccines. Recipharm's broader infrastructure enhances this global reach for development, manufacturing, and supply chain solutions.
Street Address:
Otto-Hahn-Straße 1
City:
Cuxhaven
State/Province:
Lower Saxony
Country:
Germany
Vibalogics's Global Presence
Boxborough, Massachusetts, USA
Address: 1414 Massachusetts Ave, Boxborough, MA 01719, USA
Provides US-based development and manufacturing capabilities for advanced therapies, supporting the robust North American biotech and pharmaceutical market, and facilitating clinical trial supply within the region.
Buying Intent Signals for Vibalogics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Vibalogics
As of April 2025, Vibalogics' leadership includes:
Investors of Vibalogics
Vibalogics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Following its acquisition by Recipharm in February 2022, the Vibalogics leadership team and operations were integrated into Recipharm's structure. As such, distinct executive movements solely under the Vibalogics brand are not typical; changes occur within the broader Recipharm organization, particularly its Biologics business unit.
Technology (Tech Stack) used by Vibalogics
Discover the tools Vibalogics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Vibalogics Email Formats and Examples
While Vibalogics is now part of Recipharm and communications may transition to @recipharm.com, historically, Vibalogics likely used common corporate email formats. The most probable format for @vibalogics.com (if still active or for historical contacts) would be firstname.lastname@vibalogics.com.
firstname.lastname@vibalogics.com
Format
jane.doe@vibalogics.com
Example
75%
Success rate
News and media
Recipharm • February 1, 2022
Recipharm completes the acquisition of Vibalogics, a leading CDMO in the manufacturing of viral vectors
Recipharm announced the completion of its acquisition of Vibalogics, strengthening its capabilities in biologics, particularly in viral vectors for ATMPs and vaccines. This move significantly expands Recipharm's presence in the high-growth biologics market....more
Vibalogics (via BusinessWire) • May 11, 2021
Vibalogics Completes Construction and Initiates Operations at New State-of-the-Art Boxborough, MA Facility
Vibalogics announced the completion of construction and initiation of operations at its new 110,000 sq. ft. virotherapy manufacturing facility in Boxborough, MA. The facility was designed for clinical and commercial production of viral vectors....more
Recipharm • October 26, 2023
Recipharm invests EUR 50 million in its global biologics analytical services
Recipharm announced a significant EUR 50 million investment to expand its global biologics analytical services. This investment will enhance capabilities across its network, including sites formerly part of Vibalogics, to meet growing demand for advanced analytical testing in biologics development and manufacturing....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Vibalogics, are just a search away.